The EMIF project aims to develop a common information framework of patient-level data that will link up and facilitate access to diverse medical and research data sources, opening up new avenues of research for scientists. To provide a focus and guidance for the development of the framework, the project will focus initially on questions relating to obesity and Alzheimer’s disease.
Participants
EFPIA
- GlaxoSmithKline Research and Development Ltd, Brentford, UK
- Amgen NV, Brussels, Belgium
- Boehringer Ingelheim International GmbH, Ingelheim, Germany
- F. Hoffmann-La Roche AG, Basel, Switzerland
- Institut de Recherches Internationales Servier, Suresnes, France
- Janssen Pharmaceutica NV, Beerse, Belgium
- Novo Nordisk A/S, Bagsværd, Denmark
- Pfizer Limited, Sandwich, UK
- UCB Pharma SA, Brussels, Belgium
Universities, research organisations, public bodies, non-profit groups
- Erasmus Universitair Medisch Centrum Rotterdam, Rotterdam, Netherlands
- Aarhus Universitetshospital, Aarhus Sygehus, Aarhus, Denmark
- Agenzia Regionale di Sanita, Florence, Italy
- Assistance Publique - Hôpitaux de Paris , Paris, France
- Brighton Collaboration Foundation, Basel, Switzerland
- Ealing Hospital NHS Trust, Southall, UK
- European Institute for Health Records, Lille, France
- European Molecular Biology Laboratory, Heidelberg, Germany
- Fondazione PENTA - for the Treatment and Care of Children with HIV-ONLUS, Padova, Italy
- Göteborgs Universitet, Gothenburg, Sweden
- Helsingin Yliopisto, Helsinki, Finland
- Institut für Epidemiologie und Präventionsforschung GmbH, Bremen, Germany
- Institut National de la Santé et de la Recherche Médicale, Paris, France
- Itä-Suomen Yliopisto, Kuopio, Finland
- Karolinska Institutet, Stockholm, Sweden
- King’s College London, London, UK
- Maastricht University, Maastricht, Netherlands
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften, Munich, Germany
- Medical Research Council UK, Swindon , UK
- Provincia Lombardo-Veneta - Ordine Ospedaliero di San Giovanni di Dio— Fatebenefratelli, Milan, Italy
- Tartu Ulikool, Tartu, Estonia
- Teknologian tutkimuskeskus VTT, Espoo, Finland
- Universidade de Aveiro, Aveiro, Portugal
- Università degli Studi di Pisa, Pisa, Italy
- Universität Leipzig, Leipzig, Germany
- Universitat Pompeu Fabra, Barcelona, Spain
- Universiteit Antwerpen, Antwerp, Belgium
- University College London, London, UK
- University of Cambridge, Cambridge, UK
- University of Copenhagen, Copenhagen, Denmark
- University of Glasgow, Glasgow, UK
- University of Leicester, Leicester, UK
- University of Manchester, Manchester, UK
- University Pierre et Marie Curie, Paris, France
- Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en Patiëntenzorg, Amsterdam, Netherlands
- VIB, Zwijnaarde, Belgium
Patients’ organisations
- Alzheimer Europe, Luxembourg, Luxembourg
- Universitätsklinikum Erlangen, Anstalt des Öffentlichen Rechts, Erlangen, Germany
- Vestische Kinder- und Jugendklinik Datteln, Dattien, Germany
SMEs
- Concentris Research Management GmbH, Fürstenfeldbruck, Germany
- Custodix NV, Sint-Martens-Latem, Belgium
- Electrophoretics Ltd, Cobham, UK
- GENOMEDICS S.R.L., Florence, Italy
- MAAT France, Archamps, France
- Pharmo Cooperatie UA, Utrecht, Netherlands
- Synapse Research Management Partners S.L., Barcelona, Spain
- Societa Servizi Telematici SRL, Padova, Italy• Synapse Research Management Partners S.L., Barcelona, Spain
Facts and figures
Start date: 01/10/2012
Duration: 60 months
Contributions €
- IMI funding: 24 400 000
- EFPIA in kind: 24 100 000
- Other: 7 900 000
- Total cost: 56 400 000
Contact
Project Coordinator
Bart Vannieuwenhuyse
Janssen Pharmaceutica NV
Tel: +32 14 600320
Email: BVANNIEU@its.jnj.com
Co-coordinator
Simon Lovestone
King's College London
Tel: +44 20 7848 0239
Email: simon.lovestone@kcl.ac.uk
Managing Entity
Johan van der Lei
Erasmus Universitair Medisch Centrum Rotterdam
Tel: +31 10 70 441 22
Email: j.vanderlei@erasmusmc.nl